Top Markets
Coin of the day
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Rank in Stocks #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Share Price
$0.46
Last synced: 2026-07-31
Market Cap
$3.42M
Change (1 day)
3.60%
Change (1 year)
-34.54%
Country
US
Trade Pasithea Therapeutics Corp. (KTTA)

Category

Price of KTTA with the market cap of B
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
KTTA
$0.46
Market Capitalization of Pasithea Therapeutics Corp.(KTTA)
Market Cap: $3.42M
As of August 2026 Pasithea Therapeutics Corp. has a market cap of $3.42M. This makes Pasithea Therapeutics Corp. the world's 35798th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Pasithea Therapeutics Corp. from 2021 to 2026
KTTA compared with Top 5 Most Popular stocks
Price of KTTA Asset B Mkt. of B Results
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$732,538 $3.42M
$5.452T +159,247,394.66%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$603,300 $3.42M
$4.490T +131,152,102.86%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$559,280 $3.42M
$4.162T +121,582,616.58%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$493,971 $3.42M
$3.676T +107,384,809.47%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$380,661 $3.42M
$2.833T +82,752,263.50%